Skip to content

Clinical trials

Observational Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Observational Clear all

2,715 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200016
200115
200227
200323
200423
200538
200654
200755
200858
200979
201084
201180
201285
201386
201486
201591
2016124
2017130
2018139
2019174
2020189
2021188
2022154
2023160
2024170
2025162
2026140

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed1,201
Recruiting521
Unknown status478
Terminated137
Active, not recruiting134
Not yet recruiting117
Withdrawn74
Enrolling by invitation40
Suspended13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)113
M.D. Anderson Cancer Center55
St. Jude Children's Research Hospital40
Assistance Publique - Hôpitaux de Paris39
Memorial Sloan Kettering Cancer Center31
Hospices Civils de Lyon27
National Taiwan University Hospital24
Royal Marsden NHS Foundation Trust24
Wake Forest University Health Sciences24
AbbVie21

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms2,715
Breast Neoplasms173
Lung Neoplasms113
Colorectal Neoplasms93
Prostatic Neoplasms81
Cardiovascular Diseases66
Neoplasm Metastasis63
Pancreatic Neoplasms59
Diabetes Mellitus58
Colonic Neoplasms55

Trials

Showing 1 to 25 of 2,715. Each trial links to its page on Pharma Observatory.

2,615 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.